Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pattern of weight changes following radioiodine treatment in Thai patients with Graves disease
TCTR20210920001Not yet recruiting
- Sponsor
- Theptarin Hospital
- Start
- Oct 2021
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta-minus Emitters → Radiopharmaceuticals, Gamma Emitters → Radiopharmaceuticals
- Countries
- 1
01
Overview
Open-label, single-arm trial of iodine-131 in Graves' disease, sponsored by Theptarin Hospital. Primary endpoint: Pattern of body weight change after radioiodine therapy. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
iodine-131
03
Conditions
Graves' disease
Beyond the preview
Go deeper on TCTR20210920001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210920001.